Cochrane library, Journal Year: 2021, Volume and Issue: 2021(1)
Published: Jan. 15, 2021
Language: Английский
Nature Reviews Disease Primers, Journal Year: 2016, Volume and Issue: 2(1)
Published: Oct. 27, 2016
Language: Английский
Citations
1004
Clinical Infectious Diseases, Journal Year: 2020, Volume and Issue: 71(4), P. 905 - 913
Published: Aug. 14, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans all ages affect both pulmonary extrapulmonary sites. This guideline focuses on adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, kansasii, xenopi among slowly growing abscessus rapidly NTM. A panel experts was carefully selected leading international respiratory medicine infectious diseases societies (ATS, ERS, ESCMID, IDSA) included specialists medicine, clinical microbiology, laboratory patient advocacy. Systematic reviews were conducted around each 22 PICO (Population, Intervention, Comparator, Outcome) questions recommendations formulated, written, graded using GRADE (Grading Recommendations Assessment, Development, Evaluation) approach. Thirty-one evidence-based about treatment are provided. is intended for use healthcare professionals who care patients with disease, including diseases.
Language: Английский
Citations
656
European Respiratory Journal, Journal Year: 2020, Volume and Issue: 56(1), P. 2000535 - 2000535
Published: July 1, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans all ages affect both pulmonary extrapulmonary sites. This guideline focuses on adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, kansasii , xenopi among slowly growing abscessus rapidly NTM. A panel experts was carefully selected leading international respiratory medicine infectious diseases societies (ATS, ERS, ESCMID, IDSA) included specialists medicine, clinical microbiology, laboratory patient advocacy. Systematic reviews were conducted around each 22 PICO (Population, Intervention, Comparator, Outcome) questions recommendations formulated, written, graded using GRADE (Grading Recommendations Assessment, Development, Evaluation) approach. Thirty-one evidence-based about treatment are provided. is intended for use healthcare professionals who care patients with disease, including diseases.
Language: Английский
Citations
608
Clinical Infectious Diseases, Journal Year: 2020, Volume and Issue: 71(4), P. e1 - e36
Published: March 6, 2020
Abstract Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans all ages affect both pulmonary extrapulmonary sites. This guideline focuses on adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, kansasii, xenopi among slowly growing abscessus rapidly NTM. A panel experts was carefully selected leading international respiratory medicine infectious diseases societies (ATS, ERS, ESCMID, IDSA) included specialists medicine, clinical microbiology, laboratory patient advocacy. Systematic reviews were conducted around each 22 PICO (Population, Intervention, Comparator, Outcome) questions recommendations formulated, written, graded using GRADE (Grading Recommendations Assessment, Development, Evaluation) approach. Thirty-one evidence-based about treatment are provided. is intended for use healthcare professionals who care patients with disease, including diseases.
Language: Английский
Citations
566
Nano Today, Journal Year: 2021, Volume and Issue: 37, P. 101092 - 101092
Published: Feb. 7, 2021
Language: Английский
Citations
432
New England Journal of Medicine, Journal Year: 2021, Volume and Issue: 384(18), P. 1705 - 1718
Published: May 5, 2021
Rifapentine-based regimens have potent antimycobacterial activity that may allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis.
Language: Английский
Citations
401
PLoS Medicine, Journal Year: 2018, Volume and Issue: 15(7), P. e1002595 - e1002595
Published: July 3, 2018
Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of delayed culture conversion with continued transmission in community, as well failure, relapse, and development or amplification drug resistance. We conducted a systematic review meta-analysis interventions, including directly observed therapy (DOT), determine which approaches lead improved TB outcomes. Methods findings systematically reviewed Medline references published articles for relevant studies multidrug both drug-susceptible drug-resistant through February 3, 2018. included randomized controlled trials (RCTs) prospective retrospective cohort (CSs) an internal external control group that evaluated any intervention their impact on Our search identified 7,729 articles, 129 met inclusion criteria quantitative analysis. Seven categories were identified, DOT offered by different providers at various locations, reminders tracers, incentives enablers, patient education, digital technologies (short message services [SMSs] via mobile phones video-observed [VOT]), staff combinations these interventions. When compared alone, self-administered (SAT) was associated lower rates success (CS: ratio [RR] 0.81, 95% CI 0.73–0.89; RCT: RR 0.94, 0.89–0.98), 0.83, 0.75–0.93), sputum smear (RCT: 0.92, 0.87–0.98) higher resistance 4.19, 2.34–7.49). provided healthcare providers, family members rate 0.86, 0.79–0.94). delivery community versus clinic 1.08, 1.01–1.15) end two months 1.05, 1.02–1.08) failure 0.56, 0.33–0.95) loss follow-up 0.63, 0.40–0.98). Medication monitors VOT comparable DOT. SMS led completion one RCT cure when used combination medication monitors. outcomes provider psychological employed. are limited heterogeneity lack standardized research methodology Conclusion use such education counseling, health technologies. Trained provides patient-centered options enhance improve unsupervised, SAT alone.
Language: Английский
Citations
385
American Journal of Respiratory and Critical Care Medicine, Journal Year: 2019, Volume and Issue: 200(10), P. e93 - e142
Published: Nov. 15, 2019
Section:ChooseTop
of
pageAbstract
<
Language: Английский
Citations
Expert Review of Respiratory Medicine,
Journal Year:
2021,
Volume and Issue:
15(7), P. 931 - 948
Published: May 9, 2021
Introduction:
Tuberculosis
(TB)
is
a
major
cause
of
morbidity
and
mortality
globally.
Extrapulmonary
TB
(EPTB)
constitutes
about
15%-20%
all
patients,
but
accounts
for
50%
among
HIV-coinfected.
Confirmation
microbial
diagnosis
EPTB
usually
challenging.Areas
covered:
Availability
newer
imaging
modalities
like
18FDG-PET-CT
PET-MRI
has
facilitated
precise
anatomical
localization
the
lesions
mapping
extent
EPTB.
The
use
image-
endoscopy-guided
invasive
diagnostic
methods
made
procurement
tissue/body
fluids
testing
possible.
With
advent
universal
drug-susceptibility
testing,
rapid
drug-resistance
now
possible
in
Drug-susceptible
responds
well
to
first-line
anti-TB
treatment;
meningitis,
bone
joint
lymph
node
requires
longer
durations
treatment.Expert
opinion:
Adjunctive
corticosteroids
initial
period
recommended
central
nervous
system
pericardial
TB.
Surgical
intervention
helpful
obtain
tissue
samples
diagnosis.
surgical
treatment
along
with
medical
useful
treating
complications
hydrocephalus,
Pott's
spine.
Follow-up
patients
crucial
as
prolonged,
recognition
development
immune
reconstitution
inflammatory
syndrome
(IRIS),
monitoring
adverse
events,
serious
events
drug-induced
hepatotoxicity,
organ-related
complications,
adherence.
Language: Английский
Citations
The Lancet Infectious Diseases,
Journal Year:
2018,
Volume and Issue:
18(7), P. e183 - e198
Published: March 23, 2018
Language: Английский
Citations
Extrapulmonary tuberculosis
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies